Hepatology International

, Volume 5, Issue 4, pp 955–964 | Cite as

The dissociation between the diabetes and both Child–Pugh score and in-hospital mortality in cirrhotic patients due to hepatitis B, hepatitis C, or alcoholic

  • Yu-Wei Chen
  • Han-Hsiang Chen
  • Tsang-En Wang
  • Ching-Wei Chang
  • Chen-Wang Chang
  • Wei-Che Chen
  • Chih-Jen Wu
Original Article



Up to 30% of the cirrhotic patients may clinically be classified as having diabetes. The aims of this retrospective study were to evaluate the prevalence of diabetes, its association with the severity of cirrhosis, and subsequent implication on mortality in a broad population of cirrhotic patients in Taiwan.


From January 2004 to October 2008, 4,127 cirrhotic patients were reviewed. The latest demographic data were gathered after the latest laboratory measurement in the outpatient or inpatient department. In all, 2,945 patients were included on the basis of the etiology of cirrhosis: hepatitis B, hepatitis C, hepatitis B, and hepatitis C co-infection, or alcoholics.


The observed cases of diabetes were significantly higher in cirrhotic patients than general population. Neither the Child–Pugh score (odds ratio = 0.99, p = 0.527) nor the model for end-stage liver disease score (MELD) (odds ratio = 1.00, p = 0.352) was associated with diabetes. The presence of diabetes was dissociated with renal function by means of serum creatinine (β = −0.01, p = 0.604) or estimated glomerular filtration rate (eGFR) (β = −0.02, p = 0.233), or in-hospital mortality (odds ratio = 1.08, p = 0.362).


The prevalence of diabetes was higher in cirrhotic patients in Taiwan. The prevalence of diabetes was dissociated with Child–Pugh or MELD score. The diagnosis of diabetes did not affect the renal function or in-hospital mortality in cirrhotic patients. Since the clinical outcomes of diabetes were different from cirrhotic patients to general population, it is unclear whether the treatment of diabetes and improved glycemic control will benefit cirrhotic patients.


Diabetes mellitus Liver cirrhosis Hepatitis B virus Child–Pugh score MELD score 


  1. 1.
    Garcia-Compean D, Jaquez-Quintana JO, Gonzalez-Gonzalez JA, et al. Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management. World J Gastroenterol 2009;15(3):280–288PubMedCrossRefGoogle Scholar
  2. 2.
    Postic C, Dentin R, Girard J. Role of the liver in the control of carbohydrate and lipid homeostasis. Diabetes Metab 2004;30(5):398–408PubMedCrossRefGoogle Scholar
  3. 3.
    Tolman KG, Fonseca V, Dalpiaz A, et al. Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 2007;30(3):734–743PubMedCrossRefGoogle Scholar
  4. 4.
    Megyesi C, Samols E, Marks V. Glucose tolerance and diabetes in chronic liver disease. Lancet 1967;2(7525):1051–1056PubMedCrossRefGoogle Scholar
  5. 5.
    Perseghin G, Mazzaferro V, Sereni LP, et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation. Hepatol 2000;31(3):694–703CrossRefGoogle Scholar
  6. 6.
    Kawaguchi T, Yoshida T, Harada M, et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004;165(5):1499–1508PubMedCrossRefGoogle Scholar
  7. 7.
    García-Compean D, Jaquez-Quintana JO, Maldonado-Garza H. Hepatogenous diabetes. Current views of an ancient problem. Ann Hepatol 2009;8(1):13–20PubMedGoogle Scholar
  8. 8.
    Wei JN, Chuang LM, Lin RS, et al. Prevalence and hospitalization rates of diabetes mellitus in Taiwan, 1996–2000. Taiwan J Public Health 2002;21(3):173–180Google Scholar
  9. 9.
    National Diabetes Data Group. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group. Diabetes 1979;28(12):1039–1057.Google Scholar
  10. 10.
    American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S5–S20Google Scholar
  11. 11.
    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39(2 Suppl 1):S1–S266Google Scholar
  12. 12.
    US Department of Health and Human Services. Trends in the prevalence and prevalence of self-reported diabetes mellitus—United States, 1980–1994. MMWR Morb Mortal Wkly Rep 1997;46:1014–1018Google Scholar
  13. 13.
    Reaven GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 1995;75(3):473–486PubMedGoogle Scholar
  14. 14.
    Knobler H, Schihmanter R, Zifroni A, et al. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000;75(4):355–359PubMedCrossRefGoogle Scholar
  15. 15.
    Fraser GM, Harman I, Meller N, et al. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci 1996;32(7):526–530PubMedGoogle Scholar
  16. 16.
    Papatheodoridis GV, Chrysanthos N, Savvas S, et al. Diabetes mellitus in chronic hepatitis B and C: Prevalence and potential association with the extent of liver fibrosis. J Viral Hepatol 2006;13(5):303–310CrossRefGoogle Scholar
  17. 17.
    Deschenes M, Somberg KA. Effect of transjugular intrahepatic portosystemic shunt (TIPS) on glycemic control in cirrhotic patients with diabetes mellitus. Am J Gastroenterol 1998;93(3):483PubMedCrossRefGoogle Scholar
  18. 18.
    Zein NN, Abdulkarim AS, Wiesner RH, et al. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000;32(2):209–217PubMedCrossRefGoogle Scholar
  19. 19.
    Chen YW, Wu CJ, Chang CW, et al. Renal Function in Patients with Liver Cirrhosis. Nephron Clin Pract 2011;118(2):195–203CrossRefGoogle Scholar
  20. 20.
    Adams LA, Sanderson S, Lindor KD, et al. The histological course of nonalcoholic fatty liver disease: A longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005;42(1):132–138PubMedCrossRefGoogle Scholar
  21. 21.
    Taura N, Ichikawa T, Hamasaki K, et al. Association between liver fibrosis and insulin sensitivity in chronic hepatitis C patients. Am J Gastroenterol 2006;101(12):2752–2759PubMedCrossRefGoogle Scholar
  22. 22.
    Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: Application of survival models to liver allocation. Liver Transpl 2001;7(7):567–580PubMedCrossRefGoogle Scholar
  23. 23.
    Holstein A, Hinze S, Thiessen E, et al. Clinical implications of hepatogenous diabetes in liver cirrhosis. J Gastroenterol Hepatol 2002;17(6):677–681PubMedCrossRefGoogle Scholar
  24. 24.
    Chen YW, Wu CJ, Wang TE, et al. The mortality survey of elderly cirrhotic patients in Taiwan—a single center experience. J Am Geriatr Soc 2010;58(11):2230–2232PubMedCrossRefGoogle Scholar
  25. 25.
    Trombetta M, Spiazzi G, Zoppini G, et al. Review article: Type 2 diabetes and chronic liver disease in the Verona diabetes study. Aliment Pharmacol Ther 2005;22(Suppl. 2):24–27PubMedCrossRefGoogle Scholar
  26. 26.
    Bianchi G, Marchesini G, Zoli M, et al. Prognostic significance of diabetes in patients with cirrhosis. Hepatol 1994;20(1):119–125Google Scholar
  27. 27.
    Yuan JM, Govindarajan S, Arakawa K, et al. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 2004;101(5):1009–1017PubMedCrossRefGoogle Scholar
  28. 28.
    Kawaguchi T, Taniguchi E, Morita Y, et al. Association of exogenous insulin or sulphonylurea treatment with an increased incidence of hepatoma in patients with hepatitis C virus infection. Liver Int 2010;30(3):479–486PubMedCrossRefGoogle Scholar
  29. 29.
    Donadon V, Balbi M, Ghersetti M, et al. Antidiabetic therapy and increased risk of hepatocellular carcinoma in chronic liver disease. World J Gastroenterol 2009;15(20):2506–2511PubMedCrossRefGoogle Scholar

Copyright information

© Asian Pacific Association for the Study of the Liver 2011

Authors and Affiliations

  • Yu-Wei Chen
    • 1
    • 4
  • Han-Hsiang Chen
    • 1
    • 4
    • 5
  • Tsang-En Wang
    • 2
    • 4
  • Ching-Wei Chang
    • 2
    • 4
  • Chen-Wang Chang
    • 2
    • 4
  • Wei-Che Chen
    • 3
    • 4
  • Chih-Jen Wu
    • 1
    • 4
    • 6
  1. 1.Division of Nephrology, Department of Internal MedicineMackay Memorial HospitalTaipeiTaiwan
  2. 2.Division of Gastroenterology, Department of Internal MedicineMackay Memorial HospitalTaipeiTaiwan
  3. 3.Division of Endocrinology, Department of Internal MedicineMackay Memorial HospitalTaipeiTaiwan
  4. 4.Mackay Medicine, Nursing and Management CollegeTaipeiTaiwan
  5. 5.National Taipei College of NursingTaipeiTaiwan
  6. 6.Graduate Institute of Medical ScienceTaipei Medical UniversityTaipeiTaiwan

Personalised recommendations